Home / business / COVID-19 Treatment: Cipla to manufacture and sell Eli Lilly's baricitinib in India

COVID-19 Treatment: Cipla to manufacture and sell Eli Lilly's baricitinib in India

-
To treat COVID-19 patients, US Food and Drug Administration gave Eli Lilly an emergency use approval for baricitinib in combination with remdesivir last year

from Top Business News- News18.com
Read The Rest:timesnownews...
COVID-19 Treatment: Cipla to manufacture and sell Eli Lilly's baricitinib in India COVID-19 Treatment: Cipla to manufacture and sell Eli Lilly's baricitinib in India Reviewed by Team Exprssnews on May 09, 2021 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.